Inhibition of USP7 partially impairs DNA repair by homologous recombination, which disrupts the stability of E3 ligase RAD18 and leads to the accumulation of DNA damage, therefore killing CLL cells independently of ataxia telangiectasia mutated (ATM) and p53 [127, 128]. This evidence concerns the gene USP7 and B-cell chronic lymphocytic leukemia.